Abstract
A growing body of literature suggests that 18-fluorine fluorodeoxyglucose positron emission tomography (18F-FDG PET), particularly when combined with CT, is a useful tool for the detection of infectious and inflammatory disease processes. This article will briefly review the data to date on the use of FDG PET in diagnosing musculoskeletal infections and fever of unknown origin, comparing it to conventional scintigraphic techniques in both adults and, when available, in children.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Nuclear medicine plays a vital role in evaluating infection and inflammatory conditions. Procedures commonly utilized for this purpose include: (1) either a 2- or 3-phase bone scan using technetium-99m methylene diphosphonate (Tc-99m MDP) for distinguishing acute and chronic osteomyelitis from septic arthritis or cellulitis; (2) gallium (Ga-67) citrate scanning for uncomplicated and spinal osteomyelitis, chronic infections, fever of unknown origin (FUO), and in the immunocompromised patient, and (3) technetium hexamethyl-propylene-amine oxime labeled white cells (Tc-99m HMPAO WBC) for acute, chronic or complicated osteomyelitis, a variety of lung infections, inflammatory bowel disease, complicated appendicitis or other intra-abdominal infections. Indium (In-111)-oxine autologous leukocytes, whose use in identifying infectious and inflammatory processes is prevalent in adults, is not recommended for children due to its high radiation burden [1]. The use of radiolabeled monoclonal antibodies (99mTechnetium-fanolesomab) and other potential inflammatory agents such as antibody fragments and radiolabeled peptides, has seen little application in the pediatric population.
Most of the conventional radionuclide imaging modalities suffer from relatively poor spatial resolution, and low specificity in the detection of chronic infections. Gallium 67 citrate, the archetypical agent for inflammation and infection imaging, not only lacks specificity but has the additional disadvantages of long imaging time (24–72 hours), low resolution, high physiological uptake in liver, kidneys and bowel which decreases its sensitivity in detecting suspected intra-abdominal or pelvic infections, and high patient radiation dose [2]. Disadvantages of in-vitro labeled white cell imaging include an expensive and labor-intensive labeling procedure, lack of availability, risk to health care workers involved with the handling of blood products, the possibility that severely neutropenic patients may not have sufficient leukocytes for adequate labeling, and limited success in some chronic infections [3]. Moreover, the large quantity of blood (50 ml) needed for the procedure limits its use in neonates and small children.
In recent years, growing evidence, primarily in adult patients, suggests that 18-fluorine fluorodeoxyglucose positron emission tomography (FDG PET), either alone or in combination with computed tomography (FDG PET/CT), has an important role to play in the diagnosis of a variety of infectious processes, including fever of unknown origin (FUO). FDG accumulates in a variety of infections, including abdominal, brain, lung, renal and tubo-ovarian abscesses, pneumonia, osteomyelitis, tuberculosis, Mycobacterium avium-intracellulare infection, mastitis, acute enterocolitis and infectious mononucleosis [4]. According to Basu [5] and others [3, 4, 6–10] in a series of review articles, the conditions in which FDG PET has demonstrated its greatest utility in the adult population include chronic osteomyelitis, complicated lower limb prostheses, complicated diabetic foot, fever of unknown origin, acquired immunodeficiency syndrome, and vascular graft infection and fistula.
The literature regarding the use of FDG PET/CT for identifying infection and inflammation in children is relatively sparse, although increasing. In children, FDG PET uptake has been reported in infectious processes, including osteomyelitis [11], inflammatory bowel disease [12–14], chronic granulomatous disease [15] and in evaluating fever of unknown origin in general [16, 17], and when encountered in the pre-liver transplant patient [18]. Figures 1 and 2 demonstrate abnormal FDG PET studies in two children, one with serological and biopsy-confirmed histoplasmosis and the other with infectious pneumonitis.
The use of FDG in PET is based on the observation of the increased glycolytic rate of cancer cells compared to that of normal cells. FDG, like glucose, is initially carried into the cell by the endothelial glucose transport system and is then converted to FDG-6-phosphate. However, unlike glucose, FDG is then trapped within the cell where it accumulates at a rate proportionate to glucose utilization [19]. Similar to malignant cells, activated inflammatory cells use glucose as a source of energy resulting in high FDG accumulation at sites of inflammation and infection. On the molecular level, overexpression of glucose transporter 1 (GLUT1) receptors in stimulated macrophages, neutrophils and lymphocytes has been proposed as the most likely explanation for FDG uptake in inflammatory cells [20, 21].
FDG PET and, particularly, PET/CT have several advantages over conventional nuclear medicine techniques including high spatial and contrast resolution, high sensitivity for chronic infections, minimal labor intensity, short imaging times resulting in the ability to quickly obtain results, high interobserver agreement and, when compared to Ga-67 or labeled white cell scanning, lower dose [5]. FDG PET is limited by its inability to reliably distinguish infectious from noninfectious inflammation or malignancy, limited availability, relatively high cost and, in young children, the need for sedation [5].
This article will briefly review the data to date on the use of FDG PET in diagnosing musculoskeletal infections and fever of unknown origin, comparing it to conventional scintigraphic techniques, in both adults and, when available, in children.
Musculoskeletal infections
The diagnosis of musculoskeletal infection presents an ongoing challenge, particularly in children where early recognition may be difficult or confused with other pathologies, including trauma or tumors.
Osteomyelitis, defined as any form of inflammation involving bone and/or bone marrow, is most commonly due to infection [22]. Unlike in adults where osteomyelitis commonly arises from open fractures, diabetic foot infections or surgical treatment of closed injuries, osteomyelitis in children is due to hematogenous spread of bacterial infection [23]. Staphylococcus aureus is responsible for 70-90% of cases in children [22].
In a series of review articles, authors discuss the relative merits and limitations of the anatomical and nuclear medicine imaging studies in osteomyelitis, the content of which is summarized below [23–30]. Plain films, while notoriously insensitive in the detection of acute osteomyelitis, are used to exclude other diagnostic possibilities, such as trauma or tumor, or to provide clues for underlying pathological conditions. While soft tissue swelling may be noted on plain radiographs shortly after the onset of symptoms, osseous changes are rarely seen before 7–10 days. Visualization of bony changes may be further delayed when disease involves the spine or the pelvis. The major role of computed tomography (CT) in osteomyelitis is in the detection of sequestra in cases of chronic osteomyelitis; it is also valuable in cases of vertebral osteomyelitis. Ultrasound (US) has multiple advantages: it is readily available, can be performed quickly and relatively inexpensively with little patient discomfort, and is useful in regions complicated by orthopedic hardware and for those in whom MRI is contraindicated [30]. US can detect acute osteomyelitis earlier than plain films and can be used to evaluate involvement of adjacent soft tissues in chronic osteomyelitis. Like MRI, US has the distinct advantage of eliminating patient exposure to ionizing radiation, which is so important in the pediatric population.
Of the available imaging modalities, MR is considered to have the highest sensitivity for detecting acute osteomyelitis, including associated soft tissue involvement, typically within 3–5 days after the onset of infection [23, 24, 29, 30]. When acute osteomyelitis is suspected, MR imaging may supplant inconclusive plain films, although scintigraphy is usually preferred as it is readily available, inexpensive and does not typically require sedation [23]. Finally, although anatomical imaging modalities are frequently used in assessing osteomyelitis, they are limited by lack of specificity, difficulty in distinguishing active infection from postoperative change and, particularly for CT and MRI, are limited in the presence of metallic implants.
Since their introduction in the 1970's, polyphosphates and phosphonates revolutionized the field of nuclear bone imaging. The 3-phase Tc-99m MDP bone scan, which includes an initial flow phase (acquired at 2 seconds per frame for 2 min), followed by blood pool images approximately 5–10 min following radiotracer injection, and delayed imaging 3 hours later, is the initial radionuclide procedure of choice for diagnosing acute osteomyelitis in children without underlying structural bone changes. Abnormal findings indicative of osteomyelitis on radionuclide bone scan include increased flow and blood pool activity as well as focal radiotracer accumulation in the area of interest on delayed imaging. In neonates and infants, localizing signs are generally poor or nonspecific; young children are often unable or unwilling to accurately verbalize or localize sites of pain. For these reasons, it is essential to image the entire axial and appendicular skeleton when performing radionuclide bone scans in all children.
Tc-99m MDP has a high sensitivity (82-95%) and accuracy (90%) for detecting acute, uncomplicated osteomyelitis, becoming positive within 28–48 hours after the onset of symptoms. It can reliably differentiate cellulitis (which is only positive on flow and blood pool phases) from osteomyelitis. Compared with anatomic modalities, the radionuclide bone scan has the further advantage of detecting multiple foci of disease which can be present in 7% of children and 22% of neonates. The specificity of bone scans in osteomyelitis ranges from 38-82%. Single photon emission CT (SPECT) imaging is essential in pediatric scintigraphy, allowing for improved image contrast and diagnostic accuracy [28]. On the other hand, while bone scan may detect concomitant soft tissue involvement in those with osteomyelitis, it is not accurate in fully defining local extension. Other limitations of bone scan due to its lack of specificity include the potential for false-positive and false-negative results. Bone scintigraphy can remain positive for a protracted period -- even years–following a fracture or placement of orthopedic hardware and, as a result, is of limited use in evaluating osteomyelitis in these settings. Rapidly progressive or “cold osteomyelitis” in which there is relative ischemia from vascular compression and thrombosis may be difficult to appreciate on bone scan, leading to false-negative results. Figure 3 demonstrates classic bone scan findings of osteomyelitis.
While purportedly more specific than the three-phase bone scan for osteomyelitis, gallium suffers from poor image quality, long scanning time and significantly higher patient radiation dose. Gallium scans may be particularly helpful in cases of cold osteomyelitis on bone scan. Reported sensitivities for gallium range from 25% to 80% with a specificity of 67% [23]. Prior antibiotic therapy may decrease its sensitivity. As a consequence, gallium is rarely performed.
The primary advantage of using in-vitro labeled leukocytes is increased specificity -- up to 80–90% -- compared to bone scans, particularly when complicating conditions such as fracture, presence of metallic orthopedic hardware or neuropathic joint disease are superimposed. Unfortunately, as previously stated, their performance requires the withdrawal of a large amount of blood (50 cc). It is also costly, labor intensive and has the inherent limitations related to personnel safety, including the risks of infection and cross-contamination from handling blood products. Moreover, they have very poor spatial resolution as demonstrated in Fig. 4.
Like radiolabeled white blood cell imaging, FDG PET images are not adversely affected by the presence of metallic hardware. Another advantage of FDG PET is that it rapidly normalizes following traumatic or surgical fractures as fibroblasts predominate during normal healing; likewise, FDG accumulation quickly subsides within 3–4 months following surgery [10].
Sensitivities of 98% and specificities ranging from 75% to 99% have been reported for FDG PET in acute and subacute bone and soft tissue infections in adults [6]. For osteomyelitis alone, diagnostic sensitivities and specificities were 100% and between 83% and 96% respectively. Despite these high sensitivities and specificities, as well as its other advantages, FDG PET/CT has limited value in diagnosing uncomplicated osteomyelitis compared with the combination of physical examination, evaluation of biochemical marker alteration and 3-phase bone scan or MRI [5]. This is particularly true in children given the increased need for sedation and high patient radiation dose of FDG PET/CT compared to Tc-99m MDP bone scan.
In contradistinction, in adults, FDG PET and PET/CT appear to be the imaging procedures of choice in chronic osteomyelitis where accurate diagnosis is often difficult. Not only are FDG PET and PET/CT highly effective and highly sensitive in the diagnosis of chronic osteomyelitis, but they also have a greater specificity than Ga-67, radiolabeled leukocyte or bone scintigraphy, and MRI [5]. Guhlman and colleagues were among the first to report the utility of FDG PET in chronic osteomyelitis [31]. Chacko et al. [7], evaluating a series of 56 patients with chronic osteomyelitis, reported the sensitivity, specificity and overall accuracy of FDG PET to be 91%. Meller et al. [32], in a prospective study of 30 patients, concluded that FDG PET was superior to In-111 WBC imaging for diagnosing chronic osteomyelitis in the central skeleton. deWinter et al. [33], in a series of 60 patients in whom infection was confirmed with either histopathology or microbiology, reported overall sensitivity, specificity and accuracy of FDG PET for diagnosis of chronic osteomyelitis was 100%, 88% and 93% respectively.
Fever of unknown origin
Fever of unknown origin in adults was originally defined by Petersdorf and Beeson as an illness lasting more than 3 weeks with fever >38.3 degrees Celsius on several occasions and with no diagnosis after at least 1 week of inpatient investigation [34]. Recent updated versions substitute a week of intensive outpatient evaluation, including performance of an abdominal CT, in lieu of the inpatient hospitalization [35, 36]. The definition of FUO varies even more widely in children, in whom fever is one of the most common presenting complaints, accounting for 25% of emergency department visits [37]. Mourad et al. estimate the prevalence of FUO at 2.9% of hospitalized patients [38]. Early identification of the etiology of FUO will prevent the performance of unnecessary invasive procedures and prolonged antibiotic use.
According to Tolan, most children with FUO will have a discernible cause and, although the proportion of diagnoses varies from study to study, approximately 30–35% will have an infection; 20% will have a rheumatological, autoimmune, inflammatory or granulomatous condition, 10% will have a neoplasm, 5% will have a rare condition, and 30% will remain undiagnosed (most resolving before a diagnosis can be made) [39]. These broad etiological categories and their relative incidences are remarkably similar to findings in adults.
Although the approach to the febrile child varies widely, a careful and thorough history, followed by a meticulous physical examination are invaluable in the assessment of the febrile child [39, 40]. All prior laboratory testing, including biopsies and imaging studies, should be reviewed. Reasonable screening evaluations, if not already performed, should include complete blood count, erythrocyte sedimentation rate, comprehensive metabolic profile, C-reactive protein, urinalysis with culture, blood cultures with prolonged fever, tuberculin test, urine Histoplasma antigen and other studies as appropriate for endemic pathogens, selected serologies, serum immunoglobulins including an antinuclear antibody titer, stool for blood, leukocytes, ova and parasites if symptomatic, and a chest radiograph [39].
MRI, radionuclide examinations and more invasive procedures are considered most helpful only when available information suggests pathology to be characterized [39]. Evidence of the disappointing results of imaging is documented in an early study by Steele et al. in which 109 children with FUO were evaluated [41]. Confirmed diagnoses were achieved in only 33%. Imaging included abdominal ultrasonography, abdominal CT, Tc-99m MDP bone, In-111 WBC and Ga-67 scans, upper GI and cranial CT. In 16 instances, bone marrow aspiration was performed. A total of 123 procedures were performed with positive results obtained in 22 (17%), most commonly utilizing abdominal ultrasound.
Buonomo and Treves evaluated the role of gallium scanning in 30 children with FUO [42]. Four patients had positive scans; 1/25 patients who presented with systemic signs and symptoms in addition to fever and 3/5 patients with more focal complaints which had remained occult despite imaging with other modalities. They concluded that gallium scanning is rarely useful in children with FUO and systemic complaints alone.
In more recent studies of adults with infection, Seshadri et al. found the overall sensitivity of In-111 leukocyte scintigraphy was 60%, with a specificity of 71% and positive and negative predictive values of 55% and 75% respectively [43]. Bar-Shalom et al. demonstrated an incremental contribution of SPECT/CT in gallium and labeled white cell studies for infection, providing additional information for diagnosis, localization and extent of disease in 48% [44].
FDG PET is increasingly being recognized as having utility in FUO. An early prospective study by Meller et al. compared the role of FDG PET with Ga-67 SPECT in 20 consecutive patients with FUO, reporting a sensitivity of 81% and a sensitivity of 86% for FDG PET compared to 67% and 78% respectively for Ga-67 SPECT [45]. Not only does FDG PET provide more sensitive results compared with Ga-67 or In-111 WBC, but does so within a few hours with little labor intensity.
Ferda et al., in evaluating 48 patients with FUO (mean age 57.6 years; range 15–89 years), reported that FDG PET/CT identified the cause of FUO in 44/48 patients, with findings confirmed objectively [46]. There were two cases of erroneous PET interpretation. Authors concluded that FDG PET/CT had a sensitivity of 97% and specificity of 75% in those with FUO.
Simons et al. evaluated 35 FDG PET/CT scans in 33 ventilated ICU patients (median age 58 years; range 1 month–72 years), including 5 children, suspected of having infection [16]. Twenty-four FDG PET/CT scans were abnormal; 21 were true positive; 3 were false-positive (specificity 79%), and 11 were true negative (sensitivity 100%) resulting in an overall accuracy of 91%. In five cases, the results of the PET/CT scan had direct therapeutic consequences. Simons et al. concluded that FDG PET/CT was of additional value in the evaluation of suspected infection in critically ill patients in whom conventional diagnostics did not lead to a diagnosis. A normal FDG PET/CT, with its high negative predictive value, can exclude clinically important infections requiring prolonged antibiotic therapy and can help prevent the performance of unnecessary invasive procedures.
In the first large series evaluating children, Jasper et al. retrospectively evaluated 47 FDG PET and 30 PET/CT scans obtained in 69 pediatric patients presenting with FUO (44 scans) or unexplained signs of inflammation without fever (33 scans) [17]. They found that a final diagnosis could be established in 54% of their patients. Of all the scans, 82% were abnormal, but only 45% were considered helpful by either excluding or allowing further targeted investigations. When a scan was helpful, a final diagnosis could be established in 77%. Conversely, among those 54% of patients with a final diagnosis, scans were found to have been contributory in 73%.
Finally, in a series of 11 children with biliary cirrhosis awaiting liver transplant, FDG PET was focally positive within the liver in five [18]. These FDG-positive focal lesions were confirmed either structurally or histologically to represent local infections, including infectious necrosis, focal abscess or microabscesses or suppurative cholangitis [18]. In the remaining 6 cases, where no abnormal FDG uptake was identified, no infections were detected in the liver.
Conclusion
In conclusion, FDG PET and FDG PET/CT, with its increased specificity compared to FDG PET alone, appear to be sensitive techniques for detecting various types of musculoskeletal infections and evaluating patients with FUO. However, more data is clearly needed, particularly in children, to adequately determine not only the diagnostic utility but the cost-efficacy of FDG PET/CT compared to CT, MRI, US and conventional radionuclide studies in the evaluation of infection and noninfectious inflammatory diseases.
References
Gainey MA, Siegal JA, Smergel EM et al (1988) Indium-111 labeled white blood cells: dosimetry in children. J Nucl Med 29:689–694
Dumarey N, Egrise D, Blocker D et al (2006) Imaging infection with 18 F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med 47:625–632
Petruzzi N, Shanthly N, Thakur M et al (2009) Recent trends in soft tissue infection imaging. Semin Nucl Med 39:115–123
Zhuang H, Alavi A (2002) 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 32:47–59
Basu S, Chryssikos BA, Moghadam-Kia S et al (2009) Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med 39:36–51
Stumpke KD, Dazzi H, Schaffner A et al (2000) Infection imaging using whole-body FDG-PET. Eur J Nucl Med 27:822–832
Chacko TK, Zhuang H, Nakhoda KZ (2003) Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun 24:615–624
Love C, Tomas MB, Tronco GG et al (2005) FDG PET of infection and inflammation. Radiographics 25:1357–1368
Glaudemans AWJM, Signore A (2010) FDG-PET/CT in infections: the imaging method of choice? Eur J Nucl Med Mol Imaging 37:1986–1991
Stroebel K, Stumpe KDM (2007) PET/CT in musculoskeletal infection. Semin Musculoskelet Radiol 11:353–364
Depas G, Decortis T, Francotte N et al (2007) F-18 FDG PET in infectious disease in children. Clin Nucl Med 32:593–598
Skehan SJ, Issenman R, Mertaugh J et al (1999) 18 F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet 354:836–837
Lemberg DA, Issenman RM, Cawdron R et al (2005) Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 11:733–738
Loffler M, Weckesser M, Franzius C et al (2006) High diagnostic value of 18 F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann NY Acad Sci 1072:379–385
Gungor T, Engle-Bicik I, Eich G et al (2001) Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease. Arch Dis Child 85:341–345
Simons KS, Pickkers P, Bleeker-Rovers CP et al (2010) F-18 fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med 36:504–511
Jasper N, Dabritz J, Frosch M et al (2010) Diagnostic value of [18-F]-FDG PET/CT in children with unknown origin or unexplained signs of inflammation. Eur J Nucl Med Mol Imaging 37:136–145
Sturm E, Rings EHHM, Scholvinck E et al (2006) Fluorodeoxyglucose positron emission tomography contributes to management of pediatric liver transplantation candidates with fever of unknown origin. Liver Transplant 12:1698–1704
Gallagher BM, Fowler JS, Guttersin NF et al (1987) Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F]2-deoxy-2 fluoro-D-glucose. J Nucl Med 19:1154–1161
Fu Y, Maianu L, Melbert BR et al (2004) Facilitative glucose transporter gene expression in human lymphocytes, monocytes and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 32(1):182-190
Zhao S, Kuge Y, Tsukamoto E et al (2002) Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumors: effects of insulin and glucose loading. Nucl Med Commun 23:545–550
Harik NS (2010) Management of acute hematogenous osteomyelitis in children. Expert Rev Anti Infect Ther 8(2):175-181
Pineda C, Vargas A, Rodriguez AV (2006) Imaging of osteomyelitis: current concepts. Infect Dis Clin N Am 20:789–825
Mellado Santos JM (2006) Diagnostic imaging of pediatric hematogenous osteomyelitis: lesions learned from a multi-modality approach. Eur Radiol 16:2109–2119
Ranson M (2009) Imaging of pediatric musculoskeletal Infection. Semin Musculoskelet Radiol 13:277–299
Kothari NA, Pelchovitz D, Meyer J (2001) Imaging of musculoskeletal infections. Radiol Clin North Am 39:653–671
Oudjhane K, Arouz EM (2001) Imaging of osteomyelitis in children. Radiol Clin North Am 39:251–266
Nadel H, Stillwell ME (2001) Nuclear medicine topics in pediatric musculoskeletal disease: techniques and applications. Radiol Clin North Am 39:619–651
Pruthi S, Thapa M (2009) Infectious and inflammatory disorders. Magn Reson Imaging Clin N Am 17:423–438
Pineda C, Espinosa R, Pena A (2009) Radiologic imaging of osteomyelitis: The role of plain radiography, computed tomography, ultrasonography, magnetic resonance imaging and scintigraphy. Semin Plast Surg 23(2):80-89
Guhlmann A, Brecht-Krauss D, Suger G et al (1998) Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 206:749–754
Meller J, Koster G, Liersch T et al (2002) Chronic bacterial ostermyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and (111) In-labelled autologous leukocyte scintigraphy. Eur J Nucl Med Mol Imaging 29:53–60
de Winter F, van de Wiele C, Wogelaers D et al (2001) Fluorine-18-fluoro-deoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 83-A(5):651-660
Petersdorf RG, Beeson PB (1961) Fever of unexplained origin: report on 100 cases. Medicine 40:1–30
de Klejin EM, Vanderbroucke JP, van der Meer JW (1997) Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine 76:392–400
de Klejin EM, Vanderbroucke JP, van der Meer JW (1997) Fever of unknown origin (FUO). II: diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group. Medicine 76:401–414
Marcondes Machado B, Morais Cardosa D, de Paulis M et al (2009) Fever without source: evaluation of a guideline. J Pediatr (Rio J) 85:426–432
Mourad O, Palda V, Detsky A (2003) A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 163:545–551
Tolan RW Jr (2010) Fever of unknown origin: a diagnostic approach to this vexing problem. Clin Pediatr 49:207–213
Ishimine P (2007) The evolving approach to the young child who has fever and no obvious source. Emerg Med Clin N Am 25:1087–1115
Steele RW, Jones SM, Lowe BA et al (1991) Usefulness of scanning procedures for diagnosis of fever of unknown origin in children. J Pediatr 119:526–530
Buonomo C, Treves ST (1993) Gallium scanning in children with fever of unknown origin. Pediatr Radiol 23:307–310
Seshadri N, Solanki CK, Balan K (2008) Utility of 111 In-labelled leukocyte scanning in patients with fever of unknown origin in an era of changing disease spectrum and investigational techniques. Nucl Med Commun 29:277–282
Bar-Shalom R, Yefremov N, Guralnik L et al (2006) SPECT/CT using 67 Galium and 111Indium labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 47:587–594
Meller J, Co S, Scheel AK (2007) 18 F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48:38–45
Ferda J, Ferdova E, Zahlava J et al (2010) Fever of unknown origin: a value of (18)F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging. Eur J Radiol 73:518–525
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclaimer
The supplement this article is part of is not sponsored by the industry. Dr. Parisi has no financial interests, investigational or off-label uses to disclose.
Rights and permissions
About this article
Cite this article
Parisi, M.T. Functional imaging of infection: conventional nuclear medicine agents and the expanding role of 18-F-FDG PET. Pediatr Radiol 41, 803–810 (2011). https://doi.org/10.1007/s00247-011-2013-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-011-2013-7